KRAS and familial pancreatic carcinoma: Its ability to reduce the stemness led to the apoptosis of colorectal cancer HCT116 and HT29 cells and impaired formation of tumor spheres [238], while in a few lung, colon, and pancreatic cancer cell lines, it diminished oncogenic KRAS expression [233].